The Value of FDG PET/CT in Treatment Response Assessment, Follow-Up, and Surveillance of Lung Cancer

被引：86

作者：

Sheikhbahaei, Sara ^{[1
]}

Mena, Esther ^{[1
]}

Yanamadala, Anusha ^{[1
]}

Reddy, Siddaling ^{[1
]}

Solnes, Lilja B. ^{[1
]}

Wachsmann, Jason ^{[2
]}

Subramaniam, Rathan M. ^{[1
,2
,3
]}

机构：

[1] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA

[2] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA

[3] Univ Texas Southwestern Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA

来源：

AMERICAN JOURNAL OF ROENTGENOLOGY | 2017年 / 208卷 / 02期

基金：

美国国家卫生研究院;

关键词：

FDG PET/CT; follow-up; lung cancer; recurrence detection; therapy assessment; POSITRON-EMISSION-TOMOGRAPHY; SMALL-CELL LUNG; STEREOTACTIC BODY RADIOTHERAPY; COMPUTED-TOMOGRAPHY; F-18-FDG PET/CT; NEOADJUVANT THERAPY; PULMONARY NODULES; TUMOR HYPOXIA; DIAGNOSTIC PERFORMANCE; 1ST-LINE CHEMOTHERAPY;

D O I：

10.2214/AJR.16.16532

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

OBJECTIVE. The purpose of this article is to summarize the evidence regarding the role of FDG PET/CT in treatment response assessment and surveillance of lung cancer and to provide suggested best practices. CONCLUSION. FDG PET/CT is a valuable imaging tool for assessing treatment response for patients with lung cancer, though evidence for its comparative effectiveness with chest CT is still evolving. FDG PET/CT is most useful when there is clinical suspicion or other evidence for disease recurrence or metastases. The sequencing, cost analysis, and comparative effectiveness of FDG PET/CT and conventional imaging modalities in the follow-up setting need to be investigated.

引用

页码：420 / 433

页数：14

共 89 条

[51] Prognostic Evaluation of Disease Outcome in Solid Tumors Investigated With 64Cu-ATSM PET/CT [J].

Lopci, Egesta ;

Grassi, Ilaria ;

Rubello, Domenico ;

Colletti, Patrick M. ;

Cambioli, Silvia ;

Gamboni, Alessandro ;

Salvi, Fabrizio ;

Cicoria, Gianfranco ;

Lodi, Filippo ;

Dazzi, Claudio ;

Mattioli, Sandro ;

Fanti, Stefano .

CLINICAL NUCLEAR MEDICINE, 2016, 41 (02) :E87-E92

[52] Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer [J].

Mac Manus, MP ;

Hicks, RJ ;

Matthews, JP ;

McKenzie, A ;

Rischin, D ;

Salminen, EK ;

Ball, DL .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) :1285-1292

[53] 18F-FDG PET/CT and Lung Cancer: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management [J].

Marcus, Charles ;

Paidpally, Vasavi ;

Antoniou, Alexander ;

Zaheer, Atif ;

Wahl, Richard L. ;

Subramaniam, Rathan M. .

JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (02) :204-208

[54] PET imaging of patients with non-small cell lung cancer employing an EGF receptor targeting drug as tracer [J].

Memon, A. A. ;

Weber, B. ;

Winterdahl, M. ;

Jakobsen, S. ;

Meldgaard, P. ;

Madsen, H. H. T. ;

Keiding, S. ;

Nexo, E. ;

Sorensen, B. S. .

BRITISH JOURNAL OF CANCER, 2011, 105 (12) :1850-1855

[55] Molecular Imaging with 11C-PD153035 PET/CT Predicts Survival in Non-Small Cell Lung Cancer Treated with EGFR-TKI: A Pilot Study [J].

Meng, Xue ;

Loo, Billy W., Jr. ;

Ma, Li ;

Murphy, James D. ;

Sun, Xindong ;

Yu, Jinming .

JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (10) :1573-1579

[56] Changes in 18F-Fluorodeoxyglucose and 18F-Fluorodeoxythymidine Positron Emission Tomography Imaging in Patients with Non-Small Cell Lung Cancer Treated with Erlotinib [J].

Mileshkin, Linda ;

Hicks, Rodney J. ;

Hughes, Brett G. M. ;

Mitchell, Paul L. R. ;

Charu, Veena ;

Gitlitz, Barbara J. ;

Macfarlane, David ;

Solomon, Benjamin ;

Amler, Lukas C. ;

Yu, Wei ;

Pirzkall, Andrea ;

Fine, Bernard M. .

CLINICAL CANCER RESEARCH, 2011, 17 (10) :3304-3315

[57] Metabolic response evaluated by 18F-FDG PET/CT as a potential screening tool in identifying a subgroup of patients with advanced non-small cell lung cancer for immediate maintenance therapy after first-line chemotherapy [J].

Moon, Seung Hwan ;

Cho, Su-Hee ;

Park, Lee Chun ;

Ji, Jun Ho ;

Sun, Jong-Mu ;

Ahn, Jin Sock ;

Park, Keunchil ;

Choi, Joon Young ;

Ahn, Myung-Ju .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (07) :1005-1013

[58] Primary Tumor Standardized Uptake Value Measured on F18-Fluorodeoxyglucose Positron Emission Tomography Is of Prediction Value for Survival and Local Control in Non-Small-Cell Lung Cancer Receiving Radiotherapy Meta-Analysis [J].

Na, Feifei ;

Wang, Jingwen ;

Li, Cong ;

Deng, Lei ;

Xue, Jianxin ;

Lu, You .

JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (06) :834-842

[59] Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT [J].

Nahmias, Claude ;

Hanna, Wahid T. ;

Wahl, Lindi M. ;

Long, Misty J. ;

Hubner, Karl F. ;

Townsend, David W. .

JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (05) :744-751

[60] State of the Art: Assessment in Lung Cancer in the Era of Genomic Medicine [J].

Nishino, Mizuki ;

Hatabu, Hiroto ;

Johnson, Bruce E. ;

McLoud, Theresa C. .

RADIOLOGY, 2014, 271 (01) :6-27

← 1 2 3 4 5 6 7 8 9 →